A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Perspective Therapeutics
Bristol-Myers Squibb
HiFiBiO Therapeutics
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Ipsen
Actym Therapeutics, Inc.
Travera Inc
PharmaMar
Ipsen
Ascentage Pharma Group Inc.
MacroGenics
Shenzhen BinDeBio Ltd.
Novartis
Valerio Therapeutics
Valerio Therapeutics
Precision Therapeutics
Astellas Pharma Inc